Patients referred to an urban HIV clinic frequently fail to establish care: Factors predicting failure

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 17, Issue 6, 2005, Pages 773-783

  Giordano, Thomas P ^a,b,c   Visnegarwala, Fehmida ^a,b   White Jr , A Clinton ^a,b   Troisi, Catherine L ^d   Frankowski, Ralph F ^d   Hartman, Christine M ^a,c   Grimes, Richard M ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HARRIS COUNTY HOSPITAL DISTRICT   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ETHNOLOGY; FEMALE; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OUTPATIENT; PATIENT CARE; PATIENT REFERRAL; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; RACE; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT COMPLIANCE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; URBAN HEALTH SERVICES;

EID: 23444449597     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120412331336652     Document Type: Article

References (23)

1. Aloisi, M. S., Arici, C., Balzano, R., Noto, P., Piscopo, R., Filice, G., Menichetti, F., D'Arminio Monforte, A., Ippolito, G., & Girardi, E. (2002). Behavioral correlates of adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31 Suppl 3, S145-148.
2. Arici, C., Ripamonti, D., Maggiolo, F., Rizzi, M., Finazzi, M. G., Pezzotti, P., & Suter, F. (2002). Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clinical Trials, 3, 52-57.
3. Centers for Disease Control and Prevention (2003). Advancing HIV prevention: new strategies for a changing epidemic-United States, 2003. MMWR, 52, 329-332.
4. Centers for Disease Control and Prevention (2004). Recommendations for incorporating human immunodeficiency virus (HIV) prevention into the medical care of persons living with HIV. Clinical Infectious Diseases, 38, 104-121.
5. Del Rio, C., Green, S., Abrams, C., & Lennox, J. (2001). From diagnosis to undetectable: the reality of HIV/AIDS care in the inner city. 8th Conference on Retroviruses and Opportunistic Infections, February 4-8. Chicago, IL. Abstract S21.
6. Eich-Hochli, D., Niklowitz, M. W., Clement, U., Luthy, R., & Opravil, M. (1998). Predictors of unprotected sexual contacts in HIV-infected persons in Switzerland. Archives of Sexual Behavior, 27, 77-90.
7. Gao, X., Nau, D. P., Rosenbluth, S. A., Scott, V., & Woodward, C. (2000). The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care, 12, 387-398.
8. Giordano, T. P., Hasan, Q., White, A. C., JR., & Visnegarwala, F. (2002). Association of gender and race with baseline HIV viral load and CD4 count. XIV International AIDS Conference, July 7-12, Barcelona. Abstract B10512.
9. Giordano, T. P., White, A. C., JR., Sajja, P., Graviss, E. A., Arduino, R. C., Adu-Oppong, A., Lahart, C. J., & Visnegarwala, F. (2003a). Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. Journal of Acquired Immune Deficiency Syndromes, 32, 399-405.
10. Giordano, T. P., Wright, J. A., Hasan, M. Q., White, A. C., JR., Graviss, E. A., & Visnegarwala, F. (2003b). Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy? Clinical Infectious Diseases, 37, 433-437.
11. Gordillo, V., Del Amo, J., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
12. Hays, R. B., Paul, J., Ekstrand, M., Kegeles, S. M., Stall, R., & Coates, T. J. (1997). Actual versus perceived HIV status, sexual behaviors and predictors of unprotected sex among young gay and bisexual men who identify as HIV-negative, HIV-positive and untested. AIDS, 11, 1495-1502.
13. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., Stone, V. E., Smith, D. K., & Schoenbaum, E. E. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, 2175-2182.
14. Mannheimer, S., Friedland, G., Matts, J., Child, C., & Chesney, M. (2002). The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases, 34, 1115-1121.
15. Messeri, P. A., Abramson, D. M., Aidala, A. A., Lee, F., & Lee, G. (2002). The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care, 14 Suppl 1, S15-29.
16. Novotna, L., Wilson, T. E., Minkoff, H. L., McNutt, L. A., Dehovitz, J. A., Ehrlich, I., & Des Jarlais, D. C. (1999). Predictors and risk-taking consequences of drug use among HIV-infected women. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 502-507.
17. Palacio, H., Shiboski, C. H., Yelin, E. H., Hessol, N. A., & Greenblatt, R. M. (1999). Access to and utilization of primary care services among HIV-infected women. Journal of Acquired Immune Deficiency Syndromes, 21, 293-300.
18. Samet, J. H., Freedberg, K. A., Savetsky, J. B., Sullivan, L. M., Padmanabhan, L., & Stein, M. D. (2003). Discontinuation from HIV medical care: squandering treatment opportunities. Journal of Health Care for the Poor and Underserved, 14, 244-255.
19. Samet, J. H., Freedberg, K. A., Stein, M. D., Lewis, R., Savetsky, J., Sullivan, L., Levenson, S. M., & Hingson, R. (1998). Trillion virion delay: time from testing positive for HIV to presentation for primary care. Archives of Internal Medicine, 158, 734-740.
20. Sethi, A. K., Celentano, D. D., Gange, S. J., Moore, R. D., & Gallant, J. E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37, 1112-1118.
21. Singh, N., Squier, C., Sivek, C., Wagener, M., Nguyen, M. H., & Yu, V. L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261-269.
22. Valdez, H., Lederman, M. M., Woolley, I., Walker, C. J., Vernon, L. T., Hise, A., & Gripshover, B. M. (1999). Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome. Archives of Internal Medicine, 159, 1771-1776.
23. Visnegarwala, F., Graviss, E. A., Sajja, P., White, J., A. C., & Lahart, C. J. (2000). Gender and ethnic differences in utilization of care and adherence to highly active anti-retroviral therapy (HAART) in a large urban indigent HIV clinic. XIII International AIDS Conference, July 9-14, Durban. Abstract ThPeB5016.